Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anastasia Lechiara"'
Autor:
Carolina D'Alesio, Grazia Bellese, Maria Cristina Gagliani, Anastasia Lechiara, Martina Dameri, Elena Grasselli, Luisa Lanfrancone, Katia Cortese, Patrizio Castagnola
Publikováno v:
Biology Open, Vol 8, Iss 4 (2019)
The chromodomain helicase DNA-binding 4 (CHD4), a member of the nucleosome remodeling and deacetylases (NuRD) complex, has been identified as an oncogene that modulates proliferation and migration of breast cancers (BC). ERBB2 is an oncogenic driver
Externí odkaz:
https://doaj.org/article/f5946ed76a204a50835e0ef4add938ca
Autor:
Danilo Villalta, Martina Fabris, Lorenzo Verriello, Francesca Grizzo, Emanuela Maria Mobilia, Anastasia Lechiara, Giampaola Pesce
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM).
Autor:
Matteo Gastaldi, Silvia Scaranzin, Businaro Pietro, Anastasia Lechiara, Giampaola Pesce, Diego Franciotta, Lorenzo Lorusso
Publikováno v:
Current Oncology Reports. 24:1237-1249
Paraneoplastic neurological syndromes (PNS) are caused by nervous system-targeting aberrant anti-tumoral immune responses. We review the updated criteria for PNS diagnosis, incorporating novel information on clinical phenotypes, neuronal autoantibodi
Autor:
Patrizio Castagnola, Katia Cortese, Silvia Marconi, Anastasia Lechiara, Martina Dameri, Sara Santamaria, Cinzia Aiello, Erica Tagliatti, Grazia Bellese, Maria Cristina Gagliani
Publikováno v:
Journal of Histochemistry & Cytochemistry. 69:461-473
Breast cancers (BCa) with ERBB2 amplification show rapid tumor growth, increased disease progression, and lower survival rate. Deregulated intracellular trafficking and extracellular vesicle (EVs) release are mechanisms that support cancer progressio
Autor:
Emanuela Maria Mobilia, Anastasia Lechiara, Federica Bozzano, Giorgia Anselmi, Lucilla Nobbio, Paolo Nozza, Giampaola Pesce, Fabio Bandini, Diego Franciotta
Publikováno v:
Clinical biochemistry. 107
Autor:
Sara, Santamaria, Maria Cristina, Gagliani, Grazia, Bellese, Silvia, Marconi, Anastasia, Lechiara, Martina, Dameri, Cinzia, Aiello, Erica, Tagliatti, Patrizio, Castagnola, Katia, Cortese
Publikováno v:
J Histochem Cytochem
Breast cancers (BCa) with ERBB2 amplification show rapid tumor growth, increased disease progression, and lower survival rate. Deregulated intracellular trafficking and extracellular vesicle (EVs) release are mechanisms that support cancer progressio
Autor:
Grazia Bellese, Maria Cristina Gagliani, Anastasia Lechiara, Carolina D'Alesio, Elena Grasselli, Martina Dameri, Luisa Lanfrancone, Patrizio Castagnola, Katia Cortese
Publikováno v:
Biology Open, Vol 8, Iss 4 (2019)
The chromodomain helicase DNA-binding 4 (CHD4), a member of the nucleosome remodeling and deacetylases (NuRD) complex, has been identified as an oncogene that modulates proliferation and migration of breast cancers (BC). ERBB2 is an oncogenic driver